Homepage - Evamist
Theme: salient
Plugins: * | js_composer_salient | salient-core
Language: 🇺🇸 EN-US
Colors:
Immatics combines the discovery of cancer targets with T cell receptor development to create Adoptive Cell Therapies and TCR Bispecifics.